Wird geladen...
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However, the optimal duration and sequence of therapy for this disease has yet to be determined. Also, a significant number of patients do not satisfactorily respond to currently available therapies. The Janus kinase (JAK...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Musculoskelet Dis |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315227/ https://ncbi.nlm.nih.gov/pubmed/28255337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16687481 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|